EP4073263A4 - Verfahren zur stabilen komplexbildung und entsprechende kits - Google Patents

Verfahren zur stabilen komplexbildung und entsprechende kits Download PDF

Info

Publication number
EP4073263A4
EP4073263A4 EP21737980.9A EP21737980A EP4073263A4 EP 4073263 A4 EP4073263 A4 EP 4073263A4 EP 21737980 A EP21737980 A EP 21737980A EP 4073263 A4 EP4073263 A4 EP 4073263A4
Authority
EP
European Patent Office
Prior art keywords
methods
complex formation
stable complex
related kits
kits
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP21737980.9A
Other languages
English (en)
French (fr)
Other versions
EP4073263A1 (de
Inventor
Kevin L. GUNDERSON
Norihito MURANAKA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Encodia Inc
Original Assignee
Encodia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Encodia Inc filed Critical Encodia Inc
Priority claimed from PCT/US2021/012224 external-priority patent/WO2021141924A1/en
Publication of EP4073263A1 publication Critical patent/EP4073263A1/de
Publication of EP4073263A4 publication Critical patent/EP4073263A4/de
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B20/00—Methods specially adapted for identifying library members
    • C40B20/04—Identifying library members by means of a tag, label, or other readable or detectable entity associated with the library members, e.g. decoding processes
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B70/00—Tags or labels specially adapted for combinatorial chemistry or libraries, e.g. fluorescent tags or bar codes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP21737980.9A 2020-01-07 2021-01-05 Verfahren zur stabilen komplexbildung und entsprechende kits Pending EP4073263A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202062958176P 2020-01-07 2020-01-07
PCT/US2021/012224 WO2021141924A1 (en) 2020-01-07 2021-01-05 Methods for stable complex formation and related kits

Publications (2)

Publication Number Publication Date
EP4073263A1 EP4073263A1 (de) 2022-10-19
EP4073263A4 true EP4073263A4 (de) 2023-11-08

Family

ID=76655264

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21737980.9A Pending EP4073263A4 (de) 2020-01-07 2021-01-05 Verfahren zur stabilen komplexbildung und entsprechende kits

Country Status (2)

Country Link
US (1) US11169157B2 (de)
EP (1) EP4073263A4 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021141922A1 (en) * 2020-01-07 2021-07-15 Encodia, Inc. Methods for information transfer and related kits
EP4196581B1 (de) 2020-08-19 2026-02-25 Encodia, Inc. Sequenzielle codierungsverfahren und zugehörige kits
US12474346B2 (en) 2021-11-05 2025-11-18 Encodia, Inc. Methods and kits for multicycle encoding assay
EP4430206A1 (de) 2021-11-10 2024-09-18 Encodia, Inc. Verfahren zur barcodierung von makromolekülen in einzelnen zellen
US12043862B2 (en) 2021-12-28 2024-07-23 Encodia, Inc. High-throughput serotyping and antibody profiling assays

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4004230B2 (ja) 1998-11-06 2007-11-07 株式会社三菱化学ヤトロン 架橋アビジン含有新規複合体、架橋アビジンを用いる分析方法、並びに分析用試薬及びキット
WO2000057183A1 (en) 1999-03-23 2000-09-28 Biovation Limited Protein isolation and analysis
US11118215B2 (en) 2003-09-18 2021-09-14 Nuevolution A/S Method for obtaining structural information concerning an encoded molecule and method for selecting compounds
PT3305900T (pt) 2005-12-01 2021-10-27 Nuevolution As Métodos de codificação enzimática para síntese eficaz de bibliotecas grandes
US8642744B2 (en) 2010-10-28 2014-02-04 Agilent Technologies, Inc. Crosslinking reagent for analysis of protein-protein interaction
WO2016164530A1 (en) 2015-04-07 2016-10-13 University Of Maryland, College Park Compositions and methods for high throughput protein sequencing
US10870872B2 (en) 2016-04-04 2020-12-22 President And Fellows Of Harvard College Enzymatic nucleic acid synthesis
EP3452591B1 (de) * 2016-05-02 2023-08-16 Encodia, Inc. Makromolekülanalyse mit verwendung von nukleinsäurecodierung
CA3081446A1 (en) 2017-10-31 2019-05-09 Encodia, Inc. Methods and compositions for polypeptide analysis
JP7390027B2 (ja) 2017-10-31 2023-12-01 エンコディア， インコーポレイテッド 核酸エンコーディングおよび／または標識を使用する解析のためのキット
SG11202003923PA (en) 2017-10-31 2020-05-28 Encodia Inc Methods and kits using nucleic acid encoding and/or label
KR20250152680A (ko) 2017-12-29 2025-10-23 노틸러스 서브시디어리, 인크. 단백질 식별을 위한 디코딩 접근법

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
XING SHUPING ET AL: "Techniques for the Analysis of Protein-Protein Interactions in Vivo", COMPREHENSIVE SEQUENCE ANALYSIS OF 24,783 BARLEY FULL-LENGTH CDNAS DERIVED FROM 12 CLONE LIBRARIES,, vol. 171, no. 2, 1 June 2016 (2016-06-01), pages 727 - 758, XP002761334, ISSN: 1532-2548, [retrieved on 20160425], DOI: 10.?1104/?PP.?16.?00470 *

Also Published As

Publication number Publication date
US11169157B2 (en) 2021-11-09
US20210208150A1 (en) 2021-07-08
EP4073263A1 (de) 2022-10-19

Similar Documents

Publication Publication Date Title
EP4073263A4 (de) Verfahren zur stabilen komplexbildung und entsprechende kits
EP4038178A4 (de) Nährzusammensetzungen und verfahren, kits und zellzusammensetzungen zum produzieren derselben
AU2022298331B2 (en) Methods
EP3971173A4 (de) Fluorlacton und verfahren zur herstellung davon
AU2020285524A1 (en) Methods and user interfaces for sharing audio
EP4039103A4 (de) Zusammensetzung und herstellungsverfahren dafür
EP4039789A4 (de) Screening-verfahren für sekretionsproduzierende zellen und kit zum screenen von sekretionsproduzierenden zellen
EP3849557A4 (de) Kits und verfahren zur behandlung von krebserkrankungen
EP4110413A4 (de) Biomaterialien und zugehörige verfahren und kits
EP4028058A4 (de) Zusammensetzungen und verfahren zur herstellung und verwendung von multispezifischen antikörpern
EP4025701A4 (de) Kits und verfahren zur prüfung des lungenkrebsrisikos
GB202102391D0 (en) Methods and kits
EP3978177A4 (de) Verfahren zur herstellung eines heterometallischen komplexes und heterometallischer komplex
CA3252012A1 (en) METHODS
EP4159852A4 (de) Kit und verfahren
AU2021903024A0 (en) Methods and kits therefor
HK40070096A (en) Methods for preparing analytes and related kits
CA3288513A1 (en) Anti-p95her2 antibodies and methods for their use
CA3287004A1 (en) Method and kits
HK40104694A (en) Compositions and methods for anti-pacap antibodies
HK40121852A (zh) 富集方法和试剂盒
HK40096208A (en) Sequential encoding methods and related kits
HK40087754A (en) Methods of use of anti-trem2 antibodies
HK40086308A (en) Methods of use of anti-trem2 antibodies
EM87291560001S (de) Reiseapotheken

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220712

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20231010

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/543 20060101ALI20231004BHEP

Ipc: C40B 70/00 20060101ALI20231004BHEP

Ipc: C40B 20/04 20060101ALI20231004BHEP

Ipc: C12Q 1/6869 20180101ALI20231004BHEP

Ipc: C12Q 1/6811 20180101ALI20231004BHEP

Ipc: C12Q 1/68 20180101AFI20231004BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20240827